thiotepa has been researched along with Endometrial Hyperplasia in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Endometrial Hyperplasia: Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Livshits, MA | 1 |
| Tsyrlina, EV | 1 |
1 review available for thiotepa and Endometrial Hyperplasia
| Article | Year |
|---|---|
[Hormones in the pathogenesis and treatment of malignant ovarian tumors].
Topics: Adrenal Cortex Hormones; Androgens; Animals; Clinical Trials as Topic; Drug Evaluation; Drug Therapy | 1977 |
1 trial available for thiotepa and Endometrial Hyperplasia
| Article | Year |
|---|---|
[Hormones in the pathogenesis and treatment of malignant ovarian tumors].
Topics: Adrenal Cortex Hormones; Androgens; Animals; Clinical Trials as Topic; Drug Evaluation; Drug Therapy | 1977 |